Haoxi Health Technology (HAO) Receivables (2023 - 2025)

Haoxi Health Technology's Receivables history runs 3 years deep, the most recent figure standing at -$1.0 million for Q4 2025.

• On a quarterly basis, Receivables fell 207.75% year-over-year to -$1.0 million in Q4 2025; TTM through Dec 2025 was -$1.0 million, a 207.75% decrease from a year earlier, with the FY2025 full-year figure at $729196.0, up 48.76% from the prior year.
• Receivables slipped to -$1.0 million in Q4 2025 per HAO's latest filing, from $729196.0 in the prior quarter.
• Across five years, Receivables topped out at $953839.0 in Q4 2024 and bottomed at -$1.0 million in Q4 2025.
• The 3-year median for Receivables is $490192.0 (2024), against an average of $230636.2.
• Across the five-year window, Receivables jumped 6226.69% in 2024 and sank 207.75% in 2025, its largest moves.
• Year by year, Receivables stood at $7748.0 in 2023, then jumped by 12210.78% to $953839.0 in 2024, then sank by 207.75% to -$1.0 million in 2025.
• Per Business Quant, the three latest HAO Receivables figures stand at -$1.0 million (Q4 2025), $729196.0 (Q2 2025), and $953839.0 (Q4 2024).